Fundraising Fox

CVRx

NASDAQ: CVRX

Austin, US · Founded 2001 · Delaware corporation · 261 employees on LinkedIn · 6 known investors

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical Devices

Founders & leadership

CP
Craig PalmerExecutive
NY
Nadim YaredExecutive
DB
Dean Bruhn-DingExecutive
JB
John BrintnallExecutive
LG
Liz GalleExecutive

Board

GP
Geoff PardoBoard director
JM
John M. NehraBoard director
KK
Kadir KadhiresanBoard director
ABAli Behbahani
Ali BehbahaniinBoard directorPartner, Co-Head of Healthcare at New Enterprise Associates (NEA)
TH
Tom HeymanBoard director
JS
Joseph SlatteryBoard director

Investors · 6

New Enterprise Associates (NEA)Menlo Park · $200K – $40Mvia Ali Behbahani · board
Treo Ventures, LlcMinneapolis
Windham Capital PartnersNew York · $1M – $5M
Ysios CapitalBarcelona · $5.4M – $21.6M
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M
Vensana Capitalreported · 2 sourcesMinneapolis

Reported raises · per SEC filings

Form D private placements

$125.3M disclosed across 2 rounds · 2016–2020

▶$50MraisedJul 2020 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John BrintnallExecutive Officer
  • Elizabeth GalleExecutive Officer
  • Dean Bruhn-DingExecutive Officer
  • Kirk NielsenDirector
  • Ali BehbahaniDirector
  • Kadir KadhiresanDirector
  • Mudit K. JainDirector
  • Joseph SlatteryDirector
  • Nadim YaredExecutive Officer, Director
  • Geoff PardoDirector
  • John M. NehraDirector
Offering amount
$50M
Amount sold
$50M
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$75.3MraisedMay 2019 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Craig PalmerExecutive Officer
  • Geoff PardoDirector
  • Nadim YaredExecutive Officer, Director
  • Dean Bruhn-DingExecutive Officer
  • John BrintnallExecutive Officer
  • Liz GalleExecutive Officer
  • John M. NehraDirector
  • Kadir KadhiresanDirector
  • Ali BehbahaniDirector
  • Joseph SlatteryDirector
  • Tom HeymanDirector
Offering amount
$93M
Amount sold
$75.3M
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Hackensack22 shared keywordsHackensack Meridian Health is a hospital network in New Jersey providing clinical services including neurology and neurosurgery, orthopedics, behavioral health, virtual and urgent care, and cancer care. It also operates medical education and research programs, and runs health and wellness centers across the state.

Companies competing with CVRx for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

CVRx enables first commercial Barostim implant in Washington state for heart failure treatmenttradersunion.com · Jul 2026News release: CVRx® Raises $50 Million in New Equity Financing - CVRxbarostim.com · Jul 2020CVRx's $93 million financing tops recent funding news in Minneapolishoodline.com · Jun 2019CVRx Raises Additional $12M in Series F Financing - FinSMEsfinsmes.com · Oct 2013CVRx raises $29.6M for hypertension device | Fierce Biotechfiercebiotech.com · Jul 2013

Frequently asked questions

What does CVRx do?
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
Who are CVRx's investors?
CVRx's investors include New Enterprise Associates (NEA), Treo Ventures, Llc, Windham Capital Partners, Ysios Capital, Hatteras Venture Partners, Vensana Capital.
How much funding has CVRx raised?
CVRx has disclosed $125.3M raised across 2 rounds.
Where is CVRx headquartered?
CVRx is headquartered in Austin, US.